Last week, UK biotechnology firm Oxford Cannabinoid Technologies (OCT), one of the first cannabis companies in history to list on
CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join
SUMMERWAY Capital’s (LON: SWC) £80m reverse takeover of one of the UK’s few licenced high-THC cannabis growers has seen it relaunch its shares on the London Stock Exchange (LSE) in order to fund its new acquisition.Â
On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets.Â
Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the
UK SPAC has submitted a first draft of the prospectus to the FCA and has made an application in respect of a Standard Listing.
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief in a metered dose.Â
The company is pursuing a number of “new opportunities”
It will be the first multi-brand CBD-focused consumer goods business to list on the LSE.
The company is using funding raised via the London Stock Exchange to fund the studies
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
